FIELD: medicine.
SUBSTANCE: invention refers to a pharmaceutical tablet for oral administration containing ulipristal acetate 3-18 wt %; a diluent 60 - 95 wt % specified in lactose monohydrate, microcrystalline cellulose, cellulose, mannitol and combinations thereof; a binding agent 0 - 10 wt % specified in hydroxypropyl methyl cellulose, povidone and combinations thereof; sodium croscarmellose 1 - 10 wt % and magnesium stearate 0.5 - 4 wt %.The invention also refers to a method for preparing the above tablet which involves mixing the ingredients and forming the tablet by wet granulation or direct compression.
EFFECT: invention provides the new formulation of the tablet with improved disintegration.
13 cl, 2 dwg, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| DRY GRANULATION PROCESS FOR PRODUCING TABLET COMPOSITIONS OF METFORMIN AND COMPOSITIONS THEREOF | 2013 |
|
RU2647421C2 |
| SOLID PREPARATIONS CONTAINING TOFOGLIFLOZIN, AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2700164C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
| DOSAGE FORM CONTAINING DESLORATADINE AND METHOD FOR PRODUCING IT | 2013 |
|
RU2550958C2 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING PYRIMIDIN -A-ONE DERIVATIVE, COVERED WITH INTESTINE-SOLUBLE POLYMER | 2004 |
|
RU2359660C2 |
| PHRAMACEUTICAL COMPOSITIONS CONTAINING ZD6474 | 2005 |
|
RU2383343C2 |
| METHOD FOR MELT GRANULATION | 2009 |
|
RU2491918C2 |
